Company Filing History:
Years Active: 2020-2021
Title: Daniela Cipolletta: Innovator in Cancer Therapy
Introduction
Daniela Cipolletta is a prominent inventor based in Arlington, MA, who has made significant contributions to the field of cancer therapy. With a focus on enhancing immune responses, her work has led to the development of innovative pharmaceutical compositions aimed at treating various forms of cancer. Daniela holds two patents that reflect her dedication to advancing medical science.
Latest Patents
Her latest patents include "Combined use of anti PD-1 and anti M-CSF antibodies in the treatment of cancer." This invention relates to a pharmaceutical composition that combines a PD-1 antibody and an M-CSF antibody, which can be administered independently or separately in therapeutically effective quantities for cancer treatment. Another notable patent is "Compositions and methods of use for augmented immune response and cancer therapy." This invention provides antibody compositions that enhance CD4+ and CD8+ T cell responses, aiding in the treatment and prevention of diseases that can benefit from an augmented immune response, including cancers.
Career Highlights
Daniela Cipolletta is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to collaborate with other experts in the field, furthering her research and development efforts in cancer therapy.
Collaborations
Some of her notable coworkers include Marie-Louise Fjaellskog and John Scott Cameron, who have contributed to her research initiatives and the advancement of her patented technologies.
Conclusion
Daniela Cipolletta's innovative work in cancer therapy exemplifies the impact of dedicated inventors in the medical field. Her patents and collaborations highlight her commitment to improving treatment options for patients facing cancer.